LMR Partners’s West Pharmaceutical WST Stock Holding History

LMR Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,213	Closed	-$3.25M	–	1334
2024 Q1	$3.25M	Buy	+8,213	New	+$3.04M	0.03%	438
2023 Q4	–	Sell	-4,017	Closed	-$1.51M	–	1148
2023 Q3	$1.51M	Buy	+4,017	New	+$1.55M	0.02%	433
2022 Q1	–	Sell	-450	Closed	-$211K	–	1361
2021 Q4	$211K	Buy	+450	New	+$194K	﹤0.01%	1066
2021 Q3	–	Sell	-5,477	Closed	-$1.97M	–	1215
2021 Q2	$1.97M	Buy	+5,477	New	+$1.81M	0.03%	364
2021 Q1	–	Sell	-3,186	Closed	-$903K	–	1065
2020 Q4	$903K	Buy	+3,186	New	+$894K	0.01%	294
2019 Q4	–	Sell	-43,565	Closed	-$6.18M	–	569
2019 Q3	$6.18M	Buy	43,565 +22,167	+104%	+$3.05M	0.31%	55
2019 Q2	$2.68M	Buy	+21,398	New	+$2.53M	0.1%	107
2016 Q3	–	Sell	-48,716	Closed	-$3.7M	–	496
2016 Q2	$3.7M	Buy	+48,716	New	+$3.55M	0.57%	31

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LMR Partners's WST Position: Q2 2024 in Review

LMR Partners sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 8,213 shares — an estimated $3.25M sold.

LMR Partners first reported a position in WST in Q2 2016 and held it in 8 quarters. The position peaked at $6.18M in Q3 2019. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

LMR Partners reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 8,213 West Pharmaceutical shares in Q2 2024, an estimated $3.25M.
LMR Partners first reported a position in West Pharmaceutical in Q2 2016 and held it in 8 quarters.
LMR Partners's West Pharmaceutical position peaked at $6.18M in Q3 2019.
777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.